Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Inst Medicine ChemfiledCriticalRes Inst Medicine Chem
Publication of DK134071BpublicationCriticalpatent/DK134071B/en
Application grantedgrantedCritical
Publication of DK134071CpublicationCriticalpatent/DK134071C/da
C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Health & Medical Sciences
(AREA)
General Health & Medical Sciences
(AREA)
Steroid Compounds
(AREA)
DK594370AA1969-11-241970-11-23
Process for the selective 9 (11) -enolization or enol esterification of steroid-1,4-diene-3,11-diones.
DK134071B
(en)
Analogous process for the preparation of 2,9α, -11β-trichloro-6α-fluoro-16α-methyl-Δ <1,4> -pregnadiene-17α, 21-diol-3,20-dione or esters thereof.
Analogous process for the preparation of 9α-fluoro-11β, 21-dihydroxy-16α-17α- (2-propenylidenedioxy) -pregna-1,4-diene-3,20-dione or 21-esters thereof.